{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T15:40:20Z","timestamp":1729352420628,"version":"3.27.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00520-024-08829-0","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T07:02:21Z","timestamp":1725951741000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Letter to the editor regarding the paper by A. Boileve et al.: Safety of direct oral anticoagulants in patients with advanced solid tumors receiving anti\u2011VEGF agents: a retrospective study"],"prefix":"10.1007","volume":"32","author":[{"given":"Tinhinane","family":"Inouri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Noel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u00eet","family":"Blanchet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Thomas-Schoemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"issue":"1","key":"8829_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00520-022-07533-1","volume":"31","author":"A Boileve","year":"2022","unstructured":"Boileve A et al (2022) Safety of direct oral anticoagulants in patients with advanced solid tumors receiving anti-VEGF agents: a retrospective study. Support Care Cancer 31(1):41. https:\/\/doi.org\/10.1007\/s00520-022-07533-1","journal-title":"Support Care Cancer"},{"issue":"10","key":"8829_CR2","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","volume":"122","author":"JF Timp","year":"2013","unstructured":"Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC (2013) Epidemiology of cancer-associated venous thrombosis. Blood 122(10):1712\u20131723. https:\/\/doi.org\/10.1182\/blood-2013-04-460121","journal-title":"Blood"},{"issue":"7","key":"8829_CR3","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","volume":"23","author":"D Farge","year":"2022","unstructured":"Farge D et al (2022) 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. Lancet Oncol 23(7):e334\u2013e347. https:\/\/doi.org\/10.1016\/S1470-2045(22)00160-7","journal-title":"Lancet Oncol"},{"key":"8829_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.thromres.2023.10.004","volume":"231","author":"T-F Wang","year":"2023","unstructured":"Wang T-F et al (2023) The prevalence of relevant drug-drug interactions and associated clinical outcomes in patients with cancer-associated thrombosis on concurrent anticoagulation and anticancer or supportive care therapies. Thromb Res 231:128\u2013134. https:\/\/doi.org\/10.1016\/j.thromres.2023.10.004","journal-title":"Thromb Res"},{"issue":"8","key":"8829_CR5","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1111\/jth.15367","volume":"19","author":"T Wang","year":"2021","unstructured":"Wang T et al (2021) Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies\u2014TacDOAC registry: communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy. J Thromb Haemost 19(8):2068\u20132081. https:\/\/doi.org\/10.1111\/jth.15367","journal-title":"J Thromb Haemost"},{"issue":"4","key":"8829_CR6","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s11239-020-02037-3","volume":"49","author":"S Hanigan","year":"2020","unstructured":"Hanigan S, Das J, Pogue K, Barnes GD, Dorsch MP (2020) The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding. J Thromb Thrombolysis 49(4):636\u2013643. https:\/\/doi.org\/10.1007\/s11239-020-02037-3","journal-title":"J Thromb Thrombolysis"},{"key":"8829_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40164-019-0146-9","volume":"8","author":"D Santini","year":"2019","unstructured":"Santini D, Citarella F, Vincenzi B, Russano M, Tonini G, Stellato M (2019) Cabozantinib and apixaban: an hitherto unreported interaction. Exp Hematol Oncol 8:22. https:\/\/doi.org\/10.1186\/s40164-019-0146-9","journal-title":"Exp Hematol Oncol"},{"issue":"5","key":"8829_CR8","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/fcp.12769","volume":"36","author":"L Lafaie","year":"2022","unstructured":"Lafaie L, Hodin S, Sa\u00efb S, Bin V, Bertoletti L, Delavenne X (2022) Tyrosine kinase inhibitors and direct oral anticoagulants: in vitro evaluation of drug-drug interaction mediated by P-glycoprotein. Fundam Clin Pharmacol 36(5):860\u2013868. https:\/\/doi.org\/10.1111\/fcp.12769","journal-title":"Fundam Clin Pharmacol"},{"issue":"11","key":"8829_CR9","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s40262-023-01298-4","volume":"62","author":"C Grange","year":"2023","unstructured":"Grange C, Rioufol C, Souquet P-J, Assaad S (2023) Anti-coagulant treatment of cancer-associated thrombosis in frail patients: impact of frailties on the management of drug\u2013drug interactions. Clin Pharmacokinet 62(11):1523\u20131531. https:\/\/doi.org\/10.1007\/s40262-023-01298-4","journal-title":"Clin Pharmacokinet"},{"key":"8829_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejim.2023.02.003","volume":"112","author":"MC Vedovati","year":"2023","unstructured":"Vedovati MC et al (2023) Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism. Eur J Intern Med 112:29\u201336. https:\/\/doi.org\/10.1016\/j.ejim.2023.02.003","journal-title":"Eur J Intern Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08829-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08829-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08829-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T15:07:47Z","timestamp":1729350467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08829-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["8829"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08829-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"15 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"648"}}